Unmasking the Economics of MS Treatments: Insights from Global Studies
Petrou et al.’s systematic review emphasizes the cost-effectiveness of disease-modifying therapies (DMTs) for multiple sclerosis, revealing substantial variability influenced by factors like country settings and treatment choice. Dimethyl fumarate (DMF) …
Unmasking the Economics of MS Treatments: Insights from Global Studies Read More